Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses.

Walsh SR, Seaman MS, Grandpre LE, Charbonneau C, Yanosick KE, Metch B, Keefer MC, Dolin R, Baden LR. Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses. Vaccine. 2012 Dec 17;31(1). Epub 2012 Nov 7. PMCID: PMC 3566524.

The road to an effective HIV vaccine.

Baden LR, Dolin R. The road to an effective HIV vaccine. N Engl J Med. 2012 Apr 5;366(14):1343-4. PMID: 22475599 [PubMed – indexed for MEDLINE].

Different pattern of immunoglobulin gene usage by HIV-1 compared to non-HIV-1 antibodies derived from the same infected subject.

Li L, Wang XH, Banerjee S, Volsky B, Williams C, Virland D, Nadas A, Seaman MS, Chen X, Spearman P, Zolla-Pazner S, Gorny MK. Different pattern of immunoglobulin gene usage by HIV-1 compared to non-HIV-1 antibodies derived from the same infected subject. PLoS One. 2012, 7(6): E39534.

In vivo anti-HIV activity of the heparin-activated serine protease inhibitor antithrombin III encapsulated in lymph-targeting immunoliposomes.

Asmal M, Whitney JB, Luedemann C, Carville A, Steen R, Letvin NL, Geiben-Lynn R. In vivo anti-HIV activity of the heparin-activated serine protease inhibitor antithrombin III encapsulated in lymph-targeting immunoliposomes. PLoS One. 2012;7(11):e48234. doi: 10.1371/journal.pone.0048234. Epub 2012 Nov 2. PMID: 23133620; PMCID: PMC3487854.

The structural biology of HIV-1: mechanistic and therapeutic insights.

Engelman A, Cherepanov P. The structural biology of HIV-1: mechanistic and therapeutic insights. Nat Rev Microbiol 2012 Mar 16;10(4):279-90. doi: 10.1038/nrmicro2747. PubMed PMID: 22421880; PubMed Central PMCID: PMC3588166.

Differential effects of human immunodeficiency virus type 1 capsid and cellular factors nucleoporin 153 and LEDGF/p75 on the efficiency and specificity of viral DNA integration.

Koh Y, Wu X, Ferris AL, Matreyek KA, Smith SJ, Lee K, KewalRamani VN, Hughes SH, Engelman A. Differential effects of human immunodeficiency virus type 1 capsid and cellular factors nucleoporin 153 and LEDGF/p75 on the efficiency and specificity of viral DNA integration. J Virol 2013 Jan;87(1):648-58. doi: 10.1128/JVI.01148-12. Epub 2012 Oct 24. PubMed PMID: 23097450; PubMed Central PMCID: PMC3536403.

Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy.

Tan CS, Bord E, Broge TA Jr, Glotzbecker B, Mills H, Gheuens S, Rosenblatt J, Avigan D, Koralnik IJ. Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy. J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):244-8. doi: 10.1097/QAI.0b013e31825a313c. PubMed PMID: 22549384; PubMed Central PMCID: PMC3400136.

Vaccination with adenovirus serotypes 35, 26, and 48 elicits greater innate cytokine responses than adenovirus serotype 5 in rhesus monkeys.

Teigler JE, Iampietro MJ, Barouch DH. Vaccination with adenovirus serotypes 35, 26, and 48 elicits greater innate cytokine responses than adenovirus serotype 5 in rhesus monkeys. J. Virol. 2012; 86:9590-9598.

Self-encounters of the third kind: lymph node stroma promotes tolerance to peripheral tissue antigens

Collier AY, Lee JW, Turley SJ. Self-encounters of the third kind: lymph node stroma promotes tolerance to peripheral tissue antigens. Mucosal Immunol. 2008 Jul;1(4):248-51. doi: 10.1038/mi.2008.19. Epub 2008 May 14. Erratum in: Mucosal Immunol. 2008 Nov;1(6):508. PMID: 19079186.